Vor Biopharma Inc. – NASDAQ:VOR
Vor Biopharma stock price today
$2.04
+0.77
+60.63%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 12 hours
Vor Biopharma stock price monthly change
+33.68%
month
Vor Biopharma stock price quarterly change
+33.68%
quarter
Vor Biopharma stock price yearly change
-51.71%
year
Vor Biopharma key metrics
Market Cap | 57.66M |
Enterprise value | 178.96M |
P/E | -2.18 |
EV/Sales | N/A |
EV/EBITDA | -1.32 |
Price/Sales | N/A |
Price/Book | 0.78 |
PEG ratio | 2.40 |
EPS | -1.78 |
Revenue | N/A |
EBITDA | -122.91M |
Income | -120.23M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVor Biopharma stock price history
Vor Biopharma stock forecast
Vor Biopharma financial statements
| Jun 2023 | 0 | -29.97M | |
|---|---|---|---|
| Sep 2023 | 0 | -33.19M | |
| Dec 2023 | 12.22M | -26.26M | -214.8% |
| Mar 2024 | 0 | -30.80M |
| Mar 2024 | 0 | -30.80M | |
|---|---|---|---|
| Sep 2025 | 0 | -22.81M | |
| Oct 2025 | 0 | -24.35M | |
| Dec 2025 | 0 | -25.98M |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 250986000 | 46.53M | 18.54% |
|---|---|---|---|
| Sep 2023 | 223023000 | 48.24M | 21.63% |
| Dec 2023 | 209828000 | 59.10M | 28.17% |
| Mar 2024 | 167030000 | 43.99M | 26.34% |
| Jun 2023 | -24.1M | 13.63M | 218K |
|---|---|---|---|
| Sep 2023 | -27.89M | 40.53M | 176K |
| Dec 2023 | -24.02M | 10.33M | 25K |
| Mar 2024 | -30.46M | 43.97M | 96K |
Vor Biopharma alternative data
| Aug 2023 | 133 |
|---|---|
| Sep 2023 | 133 |
| Oct 2023 | 133 |
| Nov 2023 | 133 |
| Dec 2023 | 133 |
| Jan 2024 | 133 |
| Feb 2024 | 133 |
| Mar 2024 | 168 |
| Apr 2024 | 168 |
| May 2024 | 168 |
| Jun 2024 | 168 |
| Jul 2024 | 168 |
Vor Biopharma other data
33.36%
-66.64%
of VOR is owned by hedge funds
25
-33
13.19M
-47.01M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 0 | 14645 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | ATTAR EYAL C. officer: CHIEF ME.. | Common Stock | 14,645 | $1.39 | $20,357 | ||
Sale | 5AM VENTURES VI, L.P. 10 percent owner | Common Stock | 330,706 | $15.3 | $5,059,802 | ||
Sale | PARMAR KUSH director, 10 percent owner | Common Stock | 330,706 | $15.3 | $5,059,802 | ||
Option | CHAKRABORTY TIRTHA officer: Chief Sc.. | Common Stock | 17,446 | $1.36 | $23,727 | ||
Option | CHAKRABORTY TIRTHA officer: Chief Sc.. | Employee Stock Option (right to buy) | 17,446 | $1.36 | $23,727 | ||
Purchase | RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner | Common Stock | 2,979,566 | $18 | $53,632,188 | ||
Purchase | PARMAR KUSH director, 10 percent owner | Common Stock | 555,555 | N/A | N/A | ||
Purchase | 5AM VENTURES VI, L.P. 10 percent owner | Common Stock | 555,555 | $18 | $9,999,990 |
| Insider | Compensation |
|---|---|
Dr. Robert Ang M.B.A., M.D., MBBS (1975) Pres, Chief Executive Officer & Director | $1,140,000 |
| Dr. Christopher Slapak M.D. (1959) Chief Medical Officer | $773,840 |
| Dr. Tirtha Chakraborty Ph.D. (1973) Chief Scientific Officer | $459,880 |
-
What's the price of Vor Biopharma stock today?
One share of Vor Biopharma stock can currently be purchased for approximately $2.04.
-
When is Vor Biopharma's next earnings date?
Unfortunately, Vor Biopharma's (VOR) next earnings date is currently unknown.
-
Does Vor Biopharma pay dividends?
No, Vor Biopharma does not pay dividends.
-
How much money does Vor Biopharma make?
Vor Biopharma has a market capitalization of 57.66M.
-
What is Vor Biopharma's stock symbol?
Vor Biopharma Inc. is traded on the NASDAQ under the ticker symbol "VOR".
-
What is Vor Biopharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Vor Biopharma?
Shares of Vor Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Vor Biopharma's key executives?
Vor Biopharma's management team includes the following people:
- Dr. Robert Ang M.B.A., M.D., MBBS Pres, Chief Executive Officer & Director(age: 50, pay: $1,140,000)
- Dr. Christopher Slapak M.D. Chief Medical Officer(age: 66, pay: $773,840)
- Dr. Tirtha Chakraborty Ph.D. Chief Scientific Officer(age: 52, pay: $459,880)
-
How many employees does Vor Biopharma have?
As Jul 2024, Vor Biopharma employs 168 workers.
-
When Vor Biopharma went public?
Vor Biopharma Inc. is publicly traded company for more then 4 years since IPO on 5 Feb 2021.
-
What is Vor Biopharma's official website?
The official website for Vor Biopharma is vorbio.com.
-
Where are Vor Biopharma's headquarters?
Vor Biopharma is headquartered at 100 Cambridgepark Drive, Cambridge, MA.
-
How can i contact Vor Biopharma?
Vor Biopharma's mailing address is 100 Cambridgepark Drive, Cambridge, MA and company can be reached via phone at +61 76556580.
Vor Biopharma company profile:
Vor Biopharma Inc.
vorbio.comExchange:
NASDAQ
Full time employees:
168
Industry:
Biotechnology
Sector:
Healthcare
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
100 Cambridgepark Drive
Cambridge, MA 02140
Cambridge, MA 02140
CIK: 0001817229
ISIN: US9290331084
CUSIP: 929033108
